1:46 Dr. Hyman on a Phase I Study of the Angiopoietin-2 Inhibitor MEDI3617 Targeted Oncology 634 views - 11 years ago
3:13 Dosing and Side Effect Management with Trifluridine/TipiracilTT CRC Case1 Morse Seg04 side effects Targeted Oncology 92 views - 9 years ago
1:57 Dr. Gordon J. Freeman on Toxicities Associated With Immunotherapies Targeted Oncology 738 views - 10 years ago
0:54 Dr. Jay Ciezki Talks About the Benefits of Stereotactic Body Radiation Therapy Targeted Oncology 415 views - 10 years ago
0:50 Dr. Chung: Should anti-angiogenesis therapy be continued in this patient? Targeted Oncology 310 views - 10 years ago
0:38 Dr. Rivera: What are the next treatment steps for Kim? Targeted Oncology 76 views - 11 years ago
1:10 Dr. Riess Discusses the Incidence and Survival Trends of Thymic Malignancies Targeted Oncology 444 views - 11 years ago
1:28 Options for Patients With Lung Cancer and Genetic Alterations Targeted Oncology 284 views - 5 years ago
1:18 Dr. Middleton on a Bispecific Immunotherapy for the Treatment of Melanoma Targeted Oncology 327 views - 10 years ago
1:11 Dr. Yael Cohen on VB111 as a Potential Treatment for Ovarian Cancer Targeted Oncology 195 views - 10 years ago
1:02 Dr. Keith C. Bible on Treatments Beyond the First-Line in Thyroid Cancer Targeted Oncology 206 views - 9 years ago
0:40 New Options for Overcoming Resistance to Anti-VEGF Therapy in HCC Targeted Oncology 277 views - 6 years ago